SB-480848

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SB-480848, covering 2016-08-08 to 2018-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients [Phase 2]